This filing alone is not material. However, the broader pattern of elevated insider selling (9 transactions, $8.6M over 30 days) warrants monitoring for potential negative sentiment. Watch for any material adverse news or guidance changes in upcoming filings.
Price Chart
Executive Summary
Atlas Venture Opportunity Fund I, L.P., a major venture investor, filed a Form 144 indicating intent to sell 2,466 shares of Dyne Therapeutics, with an estimated value of approximately $42,884. The proposed sale is tiny relative to Dyne's $2.9B market cap and appears to be routine portfolio rebalancing. However, the filing comes amid a cluster of 9 insider sales totaling $8.6M over the past 30 days, which merits attention.
Key Facts
- Filing by Atlas Venture Opportunity Fund I, L.P., a VC fund, not an officer/director.
- Proposed sale of 2,466 shares of Dyna Therapeutics common stock.
- Estimated market value of ~$42,884 (based on current price).
- Filing date: 2026-05-04.
- Proposed sale represents ~0.0015% of market cap (negligible).
- Recent insider selling cluster: 9 sales totaling $8.6M in the last 30 days.
Financial Impact
Negligible; proposed sale value of ~$42,884 is minimal relative to ~$2.9B market cap.
Risk Factors
- Insider selling cluster may indicate negative outlook, but this specific filing is too small to be a signal.
- Venture fund sale could be routine liquidity event, not necessarily informed selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-029910 |
| Document: 0001628280-26-029910-index.html | 0001628280-26-029910 |
| Document: 0001628280-26-029910.txt | 0001628280-26-029910 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access